{"disease":{"id":"rtt","name":"rtt"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03175328","title":"CRRT Timing in Sepsis-associated AKI in ICU","phase":"NA","overall_status":"UNKNOWN","enrollment_count":460,"lead_sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT05932589","title":"Neurophysiologic Biomarkers in Rett Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":202,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT06346106","title":"The Diagnostic Experience of Male Rett Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Children's Hospital Colorado","has_results":false},{"nct_id":"NCT03848832","title":"Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":true},{"nct_id":"NCT04252586","title":"A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":true},{"nct_id":"NCT03847571","title":"Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Tehran University of Medical Sciences","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}